Balchem Corp. 10-Q Summary: Period Ended September 30, 1998
Business Context and Reporting Period
This is an unaudited quarterly report (Form 10-Q) for Balchem Corp., a manufacturer of specialty ingredients, for the period ended September 30, 1998. The company operates in the food encapsulation, animal nutrition, and specialty products sectors. As of November 9, 1998, the company had 4,874,810 shares of common stock outstanding.
Key Financial Metrics
| Metric | Three Months Ended Sep 30, 1998 | Nine Months Ended Sep 30, 1998 |
|---|---|---|
| Net Sales | $6,583 | $21,536 |
| Net Earnings | $595 | $2,179 |
| Gross Margin | 35.7% | 39.3% |
| Operating Income | $967 | $3,477 |
| Cash from Operations | N/A | $2,972 |
| Cash and Equivalents | $937 (Sep 30, 1998) | N/A |
| Total Debt | $3,950 (Sep 30, 1998) | N/A |
| EPS (Diluted) | $0.12 | $0.44 |
Material Changes vs. Prior Period
- Quarterly Sales Decline: Net sales decreased 8% ($587) compared to the prior year quarter. This was driven by a cessation of sales to the Aquaculture industry due to economic issues in Thailand and continued softness in the food encapsulation business.
- Margin Compression: Cost of sales increased by 7 percentage points as a percent of sales for the quarter, attributed to product mix changes, unfavorable production variances from lower volume, and additional amortization from an asset buy-out.
- Operating Expenses: Total operating expenses decreased 24% ($429) year-over-year for the quarter, primarily due to reductions in salary and professional fees, partially offset by higher medical plan costs.
- Annualized Performance: For the nine-month period, net sales increased slightly by 1% ($223), while net earnings decreased 7% ($168) compared to the prior year.
- Debt Increase: Total debt rose significantly to $3,950 (up from $1,500 at year-end 1997) following a $3,000 borrowing to fund an early payment option on a contingent asset purchase.
Guidance, Outlook, and Risks
- Capital Expenditures: The company is undertaking a plant expansion for its encapsulation product line, expected to be online in early 1999. Total capital expenditures for 1998 are projected at approximately $1,400.
- Liquidity: The company maintains $2,000 in committed but unutilized credit available from its principal bank. Management states there are no known demands that will materially affect liquidity.
- Year 2000 Compliance: The company is implementing a new computer network and Year 2000 compliant software. Completion is anticipated by May 31, 1999. Estimated total costs range from $75,000 to $125,000, with approximately $50,000 incurred as of September 30, 1998.
- Forward-Looking Risks: Risks include changes in laws/regulations, market forces, adverse weather, and fluctuations in interest rates or investment markets.
Investor Verification Checklist
- Aquaculture Exposure: Verify the extent of the Thailand economic impact on future sales volumes in the aquaculture sector.
- Debt Service: Confirm the interest rate and repayment terms of the new $3,000 long-term debt obligation.
- Amortization Impact: Review the remaining amortization schedule for the $3,982 capitalized cost related to the specialty ingredients buy-out.
- Year 2000 Costs: Monitor the final cost of Year 2000 compliance against the $75k-$125k estimate and verify contingency plans for suppliers/customers.
- Plant Expansion: Track the timeline and capital requirements for the encapsulation plant expansion scheduled for early 1999.